D
David Jorgensen
Researcher at Imperial College London
Publications - 20
Citations - 5056
David Jorgensen is an academic researcher from Imperial College London. The author has contributed to research in topics: Public health & Coronavirus. The author has an hindex of 11, co-authored 17 publications receiving 2868 citations.
Papers
More filters
Journal ArticleDOI
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
Erik M. Volz,Swapnil Mishra,Meera Chand,Jeffrey C. Barrett,Robert Johnson,Lily Geidelberg,Wes Hinsley,Daniel J. Laydon,Gavin Dabrera,Áine O'Toole,Roberto Amato,Manon Ragonnet-Cronin,Ian Harrison,Ben Jackson,Cristina V. Ariani,Olivia Boyd,Nicholas J. Loman,Nicholas J. Loman,John T. McCrone,Sónia Gonçalves,David Jorgensen,Richard M. Myers,Verity Hill,David K. Jackson,Katy A. M. Gaythorpe,Natalie Groves,John Sillitoe,Dominic P. Kwiatkowski,Seth Flaxman,Oliver Ratmann,Samir Bhatt,Samir Bhatt,Susan Hopkins,Axel Gandy,Andrew Rambaut,Neil M. Ferguson +35 more
TL;DR: In this paper, the authors show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing.
Journal ArticleDOI
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
Erik M. Volz,Verity Hill,John T. McCrone,Anna Price,David Jorgensen,Áine O'Toole,Joel Southgate,Robert Johnson,Ben Jackson,Fabrícia F. Nascimento,Sara Rey,Samuel M. Nicholls,Rachel M. Colquhoun,Ana da Silva Filipe,James G Shepherd,David J Pascall,Rajiv Shah,Natasha Jesudason,Kathy Li,Ruth F. Jarrett,Nicole Pacchiarini,Matthew J. Bull,Lily Geidelberg,Igor Siveroni,Ian Goodfellow,Nicholas J. Loman,Oliver G. Pybus,David Robertson,E. Thomson,Andrew Rambaut,Thomas R. Connor +30 more
TL;DR: Investigation of the hypothesis for positive selection of Spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage.
Journal ArticleDOI
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries.
Patrick G T Walker,Charles Whittaker,Oliver J Watson,Oliver J Watson,Marc Baguelin,Marc Baguelin,Peter Winskill,Arran Hamlet,Bimandra A. Djafaara,Zulma M. Cucunubá,Daniela Olivera Mesa,W Green,Hayley A Thompson,Shevanthi Nayagam,Kylie E. C. Ainslie,Sangeeta N. Bhatia,Samir Bhatt,A Boonyasiri,Olivia Boyd,Nicholas F Brazeau,Lorenzo Cattarino,Gina Cuomo-Dannenburg,Amy Dighe,Christl A. Donnelly,Christl A. Donnelly,Ilaria Dorigatti,Sabine L. van Elsland,Richard G. FitzJohn,Han Fu,Katy A. M. Gaythorpe,Lily Geidelberg,Nicholas C. Grassly,D Haw,Sarah Hayes,Wes Hinsley,Natsuko Imai,David Jorgensen,Edward Knock,Daniel J Laydon,Swapnil Mishra,Gemma Nedjati-Gilani,Lucy C Okell,H. Juliette T. Unwin,Robert Verity,Michaela A. C. Vollmer,Caroline E. Walters,Haowei Wang,Y Wang,Xiaoyue Xi,David G. Lalloo,Neil M. Ferguson,Azra C. Ghani +51 more
TL;DR: Modeling reveals differences in the unfolding COVID-19 epidemics and responses to their control among countries with different income levels and combines data on demography, contact patterns, disease severity, and health care capacity and quality to understand its impact and inform strategies for its control.
Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries
Seth Flaxman,Swapnil Mishra,Axel Gandy,H Unwin,Helen Coupland,Thomas A. Mellan,Harrison Zhu,Tresnia Berah,Jeffrey W. Eaton,PN Perez Guzman,Nora Schmit,Lucia Cilloni,Kylie E. C. Ainslie,Marc Baguelin,Isobel M. Blake,A Boonyasiri,Olivia Boyd,Lorenzo Cattarino,Constanze Ciavarella,Leslie T. Cooper,Z Cucunuba Perez,Gina Cuomo-Dannenburg,Amy Dighe,A Djaafara,Ilaria Dorigatti,S Van Elsland,Richard G. FitzJohn,Han Fu,Katy A. M. Gaythorpe,Lily Geidelberg,Nicholas C. Grassly,W Green,Timothy B. Hallett,Arran Hamlet,Wes Hinsley,B Jeffrey,David Jorgensen,Edward Knock,Daniel J Laydon,G Nedjati Gilani,Pierre Nouvellet,Kris V Parag,Igor Siveroni,H Thompson,Robert Verity,Erik M. Volz,Caroline E. Walters,Haowei Wang,Y Wang,Oliver J Watson,Peter Winskill,Xiaoyue Xi,Charles Whittaker,Patrick G T Walker,Azra C. Ghani,Christl A. Donnelly,Steven Riley,Lucy C Okell,Michaela A. C. Vollmer,Neil M. Ferguson,Samir Bhatt +60 more
TL;DR: Seth Flaxman, Swapnil Mishra, Axel Gandy, H Juliette T Unwin, Helen Coupland, Thomas A Mellan, Harrison Zhu, Tresnia Berah, Jeffrey W Eaton, Pablo N P Guzman, Nora Schmit, Lucia Cilloni, Kylie E C Ainslie, Marc Baguelin, Isobel Blake, Adhiratha Boonyasiri, Olivia Boyd, Lorenzo Cattarino, Constanze
Posted ContentDOI
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
Erik M. Volz,Swapnil Mishra,Meera Chand,Jeffrey C. Barrett,Robert Johnson,Lily Geidelberg,Wes Hinsley,Daniel J Laydon,Gavin Dabrera,Áine O'Toole,Roberto Amato,Manon Ragonnet-Cronin,Ian Harrison,Ben Jackson,Cristina V. Ariani,Olivia Boyd,Nicholas J. Loman,John T. McCrone,Sónia Gonçalves,David Jorgensen,Richard M. Myers,Verity Hill,David K. Jackson,Katy A. M. Gaythorpe,Natalie Groves,John Sillitoe,Dominic P. Kwiatkowski,Cog-Uk,Seth Flaxman,Oliver Ratman,Samir Bhatt,Susan Hopkins,Axel Gandy,Andrew Rambaut,Neil M. Ferguson +34 more
TL;DR: The SARS-CoV-2 lineage B.7, now designated Variant of Concern 202012/01 (VOC) by Public Health England, originated in the UK in late Summer to early Autumn 2020 as mentioned in this paper.